(Q34751236)

English

Two-year safety and efficacy of ranibizumab 0.5 mg in diabetic macular edema: interim analysis of the RESTORE extension study

scientific article

Statements

Two-year safety and efficacy of ranibizumab 0.5 mg in diabetic macular edema: interim analysis of the RESTORE extension study (English)
Gabriele E Lang
András Berta
Bora M Eldem
Christian Simader
Dianne Sharp
Florian Sutter
Ortrud Gerstner
RESTORE Extension Study Group
2004-2012

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit